76075-15-5 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
Methyl 2,3-dihydro-3-(phenylmethyl)-2-thioxo-1H-imidazole-4-carboxylate is used as a chemical intermediate in the synthesis of new medications. Its unique molecular structure allows it to interact with biological systems, potentially leading to the development of therapeutics for various medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, methyl 2,3-dihydro-3-(phenylmethyl)-2-thioxo-1H-imidazole-4-carboxylate is used as a building block for the design and synthesis of novel compounds with potential pharmacological activity. Its versatile chemical properties enable the creation of new drug candidates with improved efficacy and selectivity.
Used in Drug Discovery:
Methyl 2,3-dihydro-3-(phenylmethyl)-2-thioxo-1H-imidazole-4-carboxylate is employed in drug discovery processes to identify and optimize potential drug candidates. Its ability to interact with biological targets makes it a valuable tool in the search for new therapeutic agents.
Used in Chemical Synthesis:
In the chemical synthesis industry, methyl 2,3-dihydro-3-(phenylmethyl)-2-thioxo-1H-imidazole-4-carboxylate is used as a reagent or starting material for the preparation of various organic compounds. Its unique structure and functional groups make it a useful component in the synthesis of complex organic molecules.
Used in Biochemical Research:
Methyl 2,3-dihydro-3-(phenylmethyl)-2-thioxo-1H-imidazole-4-carboxylate is utilized in biochemical research to study its interactions with biological systems and explore its potential as a pharmacological agent. This research can provide valuable insights into the compound's mechanism of action and its potential applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 76075-15-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,0,7 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 76075-15:
(7*7)+(6*6)+(5*0)+(4*7)+(3*5)+(2*1)+(1*5)=135
135 % 10 = 5
So 76075-15-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2S/c1-16-11(15)10-7-13-12(17)14(10)8-9-5-3-2-4-6-9/h2-7H,8H2,1H3,(H,13,17)
76075-15-5Relevant academic research and scientific papers
Improved specific synthesis of [1′-15N]- and [3′-15N]L-histidine
Soede-Huijbregts,Van Laren,Hulsbergen,Raap,Lugtenburg
, p. 831 - 841 (2007/10/03)
Specifically, 15N-enriched L-histidines have been prepared. The labelling methodology involves introduction of labels in its precursor 1-benzyl-5-hydroxy methyl imidazole, which is converted into L-histidine via the Schoellkopf method. The procedure allows the preparation of the intermediates and finally histidine with high 15N enrichment (99%) at each position, in 29% overall yield starting with 15NH4Cl and 56% with KSC15N, respectively. Copyright
Imidazole derivatives with potential biological activity
Belgodere,Bossio,Parrini,Pepino
, p. 1051 - 1056 (2007/10/02)
A series of 1-substituted imidazole-5-carbohydroxamic acids Ia, Ib and Ie were prepared from the corresponding 5-methoxycarbonyl imidazoles (IX) obtained by a univocal synthesis starting with the reaction of the amines (III) with ethylchloroacetate. On treatment of 4(5)-methoxycarbonyl imidazoles (XI) with alkylar halides (X), on the contrary, mixtures of 1-substituted-4(or 5)-methoxycarbonyl imidazoles were obtained that, when separated by thin-layer chromatography, gave the carbohydroxamic acids Ia, Ib, Id and Ie and IIa→f. The structures of the imidazole derivatives were obtained by means of IR, NMR and UV spectra. On carrying out tests of biological activity on these compounds, it had been found that the 5-carbohydroxamic acids possess, compared to the 4-carbohydroxamic ones, a greater activity. Particularly Ib and Ib-HCl seem fairly active against Klebsiella pneumoniae and Clostridium bifermentans, Ib-HCl against Bacillus subtilis, too.
